Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Oertel

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 29, 2024
Knowledge and competences in hematological malignancies amongst radiation oncology residents in Germany-results from a national surveyStephan Rehn, Michael Oertel, Philipp Linde, et al.
Hepatology (Baltimore, Md.)|April 30, 2003
Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectorsMichael Oertel, Richard Rosencrantz, Yuan-Qing Chen, et al.
Hepatology (Baltimore, Md.)|February 2, 2021
Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic ImplicationsJunyan Tao, Yekaterina Krutsenko, Akshata Moghe, et al.
Cancers|March 19, 2020
Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter AnalysisKhaled Elsayad, Michael Oertel, Laila König, et al.
Frontiers in Oncology|May 22, 2023
Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma- a risk stratified analysis of the GHSG HD17 trialMichael Oertel, Dominik Hering, Christian Baues, et al.
Cancers|December 23, 2023
Impact of Modern Low Dose Involved Site Radiation Therapy on Normal Tissue Toxicity in Cervicothoracic Non-Hodgkin Lymphomas: A Biophysical StudyJulian Roers, Daniel Rolf, Andrea Baehr, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2024
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study GroupJohannes Rosenbrock, Helen Kaul, Michael Oertel, et al.
Gastroenterology|May 13, 2022
NOTCH-YAP1/TEAD-DNMT1 Axis Drives Hepatocyte Reprogramming Into Intrahepatic CholangiocarcinomaShikai Hu, Laura Molina, Junyan Tao, et al.
Transplantation|December 24, 2016
Regeneration and Cell Recruitment in an Improved Heterotopic Auxiliary Partial Liver Transplantation Model in the RatYoshihiro Ono, Angelica Pérez-Gutiérrez, Mladen I Yovchev, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 17, 2019
Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patientsKhaled Elsayad, Gabriele Reinartz, Michael Oertel, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 29, 2024
Knowledge and competences in hematological malignancies amongst radiation oncology residents in Germany-results from a national surveyStephan Rehn, Michael Oertel, Philipp Linde, et al.
Hepatology (Baltimore, Md.)|April 30, 2003
Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectorsMichael Oertel, Richard Rosencrantz, Yuan-Qing Chen, et al.
Hepatology (Baltimore, Md.)|February 2, 2021
Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic ImplicationsJunyan Tao, Yekaterina Krutsenko, Akshata Moghe, et al.
Cancers|March 19, 2020
Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter AnalysisKhaled Elsayad, Michael Oertel, Laila König, et al.
Frontiers in Oncology|May 22, 2023
Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma- a risk stratified analysis of the GHSG HD17 trialMichael Oertel, Dominik Hering, Christian Baues, et al.
Cancers|December 23, 2023
Impact of Modern Low Dose Involved Site Radiation Therapy on Normal Tissue Toxicity in Cervicothoracic Non-Hodgkin Lymphomas: A Biophysical StudyJulian Roers, Daniel Rolf, Andrea Baehr, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2024
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study GroupJohannes Rosenbrock, Helen Kaul, Michael Oertel, et al.
Gastroenterology|May 13, 2022
NOTCH-YAP1/TEAD-DNMT1 Axis Drives Hepatocyte Reprogramming Into Intrahepatic CholangiocarcinomaShikai Hu, Laura Molina, Junyan Tao, et al.
Transplantation|December 24, 2016
Regeneration and Cell Recruitment in an Improved Heterotopic Auxiliary Partial Liver Transplantation Model in the RatYoshihiro Ono, Angelica Pérez-Gutiérrez, Mladen I Yovchev, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 17, 2019
Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patientsKhaled Elsayad, Gabriele Reinartz, Michael Oertel, et al.
Pageof 13